Pharmagreen Biotech Inc. announced that it has been approved by Amazon Seller Central for online sales via Amazon's e-commerce platform for its MaxGenomicTM Supplement. The company is also developing additional sales channels, both online and brick-and-mortar, for the MaxGenomicTM supplements. Pharmagreen's long term focus is to develop organic formulations based on mushrooms and therapeutic plants, expanding the business through white labelling services as well as through industry mergers and/or acquisitions.

Pharmagreen's second formulation is currently under development, headed by Ethan Styles, Vice President of Product Research and Development. Formulated for athletes to aid in their workout sessions, the product is consumed a few minutes prior to a workout, immediately releasing active ingredients and boosting efficacy to maximum levels. This product formulation is based on the same scientific nutritional genomic principles as MaxGenomicTM.

Nutritional genomics concerns the relationship between nutrients, diet, and genetic expression, and Pharmagreen products utilize all natural compounds from beneficial/therapeutic fungi and plants.